TRACON Pharmaceuticals, Inc.
TCON · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $3,339 | $19,603 | $8,626 | $6,606 |
| - Cash | $6,270 | $7,891 | $8,564 | $7,763 |
| + Debt | $0 | $0 | $732 | $700 |
| Enterprise Value | -$2,931 | $11,712 | $794 | -$457 |
| Revenue | $55 | $100 | $3,045 | $0 |
| % Growth | -45% | -96.7% | – | – |
| Gross Profit | $55 | $96 | $3,042 | -$4 |
| % Margin | 100% | 96% | 99.9% | – |
| EBITDA | -$2,908 | -$3,208 | $405 | $11,417 |
| % Margin | -5,287.3% | -3,208% | 13.3% | – |
| Net Income | -$2,839 | -$3,168 | $439 | $10,763 |
| % Margin | -5,161.8% | -3,168% | 14.4% | – |
| EPS Diluted | -0.94 | -1.33 | 0.18 | 5.8 |
| % Growth | 29.3% | -838.9% | -96.9% | – |
| Operating Cash Flow | -$2,769 | -$2,543 | -$522 | $15,052 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,769 | -$2,543 | -$522 | $15,052 |